C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 237/14 (2006.01) A61K 31/50 (2006.01) A61K 31/501 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 401/12 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2688517
Compounds of formula (I), where R1, R2, R3, R4, R5 and X have the meanings given in claim 1 are tyrosine kinase inhibitors, in particular of Met-kinase and amongst other things can be used for treating tumours.
Composés de formule (I) dans laquelle R1, R2, R3, R4, R5 et X possèdent la signification figurant dans la revendication 1, qui sont des inhibiteurs des tyrosine kinases, en particulier des Met-kinases, et peuvent entre autres être utilisés pour traiter des tumeurs.
Blaukat Andree
Dorsch Dieter
Schadt Oliver
Stieber Frank
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Aryl ether pyridazinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl ether pyridazinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl ether pyridazinone derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1377045